May 30, 2019
Aldeyra Therapeutics to Participate in the Jefferies 2019 Global Healthcare Conference
May 09, 2019
Aldeyra Therapeutics Announces First Quarter 2019 Financial Results and Provides Corporate Update
May 02, 2019
Aldeyra Therapeutics to Report First Quarter 2019 Financial Results and Host Conference Call on Thursday, May 9, 2019
Apr 30, 2019
Aldeyra Therapeutics Announces Last Patient Dosed in the SOLACE Phase 3 Clinical Trial
Apr 09, 2019
Aldeyra Therapeutics Announces Presentation of Phase 2b Dry Eye Disease Results at the 2019 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
Mar 26, 2019
Aldeyra Therapeutics Announces Positive Top-Line Results from the Phase 3 ALLEVIATE Trial in Patients with Allergic Conjunctivitis
Mar 25, 2019
Aldeyra Therapeutics Schedules Webcast and Conference Call to Announce Top-Line Results from the Phase 3 ALLEVIATE Trial in Allergic Conjunctivitis
Mar 08, 2019
Aldeyra Therapeutics Announces Year-End 2018 Financial Results
Mar 01, 2019
Aldeyra Therapeutics to Report Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on Friday, March 8, 2019
Feb 28, 2019
Aldeyra Therapeutics Provides Update on Ophthalmic Programs at 2019 Research & Development Day
Feb 12, 2019
Aldeyra Therapeutics to Host 2019 Research & Development Day
Jan 29, 2019
Aldeyra Therapeutics Expands Retinal Disease Pipeline with Acquisition of Helio Vision
Jan 15, 2019
Aldeyra Therapeutics Announces Promotion of Stephen G. Machatha, Ph.D. to Position of Senior Vice President of Technical Operations
Jan 03, 2019
Aldeyra Therapeutics Announces Promotion of David McMullin to Position of Chief Commercial Officer
Dec 20, 2018
Aldeyra Therapeutics Announces Last Patient Dosed in the ALLEVIATE Phase 3 Clinical Trial
Nov 28, 2018
Aldeyra Therapeutics to Participate at Citi's 2018 Global Healthcare Conference
Nov 14, 2018
Aldeyra Therapeutics Announces Third Quarter 2018 Financial Results
Nov 06, 2018
Aldeyra Therapeutics to Present at the 2018 Stifel Healthcare Conference
Nov 05, 2018
Aldeyra Therapeutics Schedules Webcast and Conference Call to Provide Third Quarter 2018 Financial Results
Sep 27, 2018
Aldeyra Therapeutics, Inc. Announces Public Offering of Common Stock